Nektar Therapeutics (NKTR) Misses Q1 EPS by 182c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $71.38 -1.57%
Financial Fact:
Cost of goods sold: 7.03M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Cost of goods sold: 7.03M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q1 EPS of ($1.82). Revenue for the quarter came in at $10.9 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- Green Rise Foods Announces Q2 Fiscal 2026 Financial Results
- Hyper Bit Technologies Announces Closing of Private Placement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
